Inoperable group | Irresectable group | P value | |
---|---|---|---|
N = 127 | 33 | 94 | |
Sex | 0.21 | ||
Male n (%) | 20 (61%) | 68 (72%) | |
Female n (%) | 13 (39%) | 26 (28%) | |
Age (years) (mean and SD) | 72 (9) | 63 (10) | 0.00 |
Range | 53-89 | 25-84 | |
BMI (kg/m2) (mean and SD) | 24.1 (5.4) | 23.6 (3.6) | 0.65 |
BSA (m2) (mean and SD) | 2.0 (0.6) | 1.8 (0.2) | 0.16 |
Tumor length (cm) (mean and SD) | 5.2 (2.7) | 6.5 (2.7) | 0.04 |
Stage I/II | 13 (40.6%) | n.a. | |
Stage III/IV | 19 (59.4%) | 100% | |
Missing | 1 | ||
Histology | 0.14 | ||
Adenocarcinoma | 18 (55%) | 35 (37%) | |
Squamous cell car. | 12 (36%) | 53 (56%) | |
NNO | 3 (9%) | 6 (6%) | |
Laboratory | |||
Creatinine μmol/l (median and IQR) | 79 (64–105) | 70 (60–82) | 0.03 |
Albumin U/l (mean and SD) | 43 (4) | 43 (4) | 0.99 |
Hemoglobin mmol/l (mean and SD) | 8.6 (1.0) | 8.4 (1.0) | 0.38 |